In human washed blood cells also evidence of hemolysis was found with non-commercial formulations at fosaprepitant concentrations of 2.3 mg/ ml and higher, although tests in human whole blood were negative.
Kuigi inimese täisvere testid olid negatiivsed, esines pestud vererakkudel hemolüüsi, kui fosaprepitandi mitteturustatavate preparaatide kontsentratsioonid olid 2, 3 mg/ ml ja suuremad.